TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

(2010) Massimo Ammirante et al.   NATURE

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma

(2010) Nallasivam Palanisamy et al.   NATURE MEDICINE

Mouse Prostate Cancer Cell Lines Established from Primary and Postcastration Recurrent Tumors

(2010) Chun-Peng Liao et al.   Hormones & Cancer

Tpl2 Is a Key Mediator of Arsenite-Induced Signal Transduction

(2009) K. M. Lee et al.   CANCER RESEARCH

TLR4 Polymorphisms and Ageing: Implications for the Pathophysiology of Age-Related Diseases

(2009) Carmela Rita Balistreri et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer

(2009) Gerardo Gatti et al.   PROSTATE

In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors

(2008) R. Snoek et al.   CLINICAL CANCER RESEARCH

BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma

(2008) Joseph H. Jeong et al.   PLoS One

Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity

(2007) Hong Seok Choi et al.   FASEB JOURNAL